PL1678182T3 - Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn - Google Patents

Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn

Info

Publication number
PL1678182T3
PL1678182T3 PL04796445T PL04796445T PL1678182T3 PL 1678182 T3 PL1678182 T3 PL 1678182T3 PL 04796445 T PL04796445 T PL 04796445T PL 04796445 T PL04796445 T PL 04796445T PL 1678182 T3 PL1678182 T3 PL 1678182T3
Authority
PL
Poland
Prior art keywords
triazolo
pyrazolo
pyrimidines
amino
preparing substituted
Prior art date
Application number
PL04796445T
Other languages
English (en)
Inventor
Shen-Chun Kuo
David Jieh-Shyh Tsai
Loc Thanh Tran
Pengyi Zhang
Andrew D Jones
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PL1678182T3 publication Critical patent/PL1678182T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PL04796445T 2003-10-28 2004-10-26 Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn PL1678182T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51505103P 2003-10-28 2003-10-28
EP04796445A EP1678182B1 (en) 2003-10-28 2004-10-26 Process for preparing substituted 5-amino-pyrazolo- [4,3-e]-1,2,4-triazolo [1,5-c]pyrimidines
PCT/US2004/035472 WO2005044819A1 (en) 2003-10-28 2004-10-26 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines

Publications (1)

Publication Number Publication Date
PL1678182T3 true PL1678182T3 (pl) 2007-05-31

Family

ID=34572798

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04796445T PL1678182T3 (pl) 2003-10-28 2004-10-26 Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn

Country Status (19)

Country Link
US (4) US7223861B2 (pl)
EP (1) EP1678182B1 (pl)
JP (2) JP4782693B2 (pl)
CN (2) CN101899050A (pl)
AR (1) AR046560A1 (pl)
AT (1) ATE353331T1 (pl)
CA (1) CA2543431A1 (pl)
CY (1) CY1106393T1 (pl)
DE (1) DE602004004677T2 (pl)
DK (1) DK1678182T3 (pl)
ES (1) ES2278353T3 (pl)
HK (1) HK1086008A1 (pl)
HR (1) HRP20070063T3 (pl)
MX (1) MXPA06004722A (pl)
PL (1) PL1678182T3 (pl)
PT (1) PT1678182E (pl)
SI (1) SI1678182T1 (pl)
WO (1) WO2005044819A1 (pl)
ZA (1) ZA200603307B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100384847C (zh) * 2000-05-26 2008-04-30 先灵公司 腺苷A2a受体拮抗剂
ES2278353T3 (es) * 2003-10-28 2007-08-01 Schering Corporation Procedimiento para preparar 5-amino-pirazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pirimidinas sustituidas.
ATE556712T1 (de) * 2005-06-07 2012-05-15 Kyowa Hakko Kirin Co Ltd A2a antagonisten zur behandlung von motorischen störungen
EP2462144B1 (en) * 2009-08-07 2017-09-20 Merck Sharp & Dohme Corp. PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
US20110144049A1 (en) * 2009-10-21 2011-06-16 Serebruany Victor L Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke with Cyclopentyl-Triazolo-Pyrimidine or Derivative Thereof
WO2013024474A1 (en) * 2011-08-18 2013-02-21 Mapi Phrarma Ltd. Polymorphs of preladenant
JPWO2013168196A1 (ja) 2012-05-10 2015-12-24 ユニテクノ株式会社 半導体搬送テスト治具
ES2749100T3 (es) * 2014-09-26 2020-03-19 Hoffmann La Roche Procesos para preparar compuestos de (ciclopentil[d]pirimidin-4-il)piperazina
MX2021006329A (es) 2018-11-30 2021-08-11 Merck Sharp & Dohme Llc Derivados de amino triazolo quinazolina 9-sustituidos como antagonistas del receptor de adenosina, composiciones farmaceuticas y su uso.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039733A1 (de) * 1990-12-13 1992-06-17 Basf Ag Substituierte 5-aminopyrazole
IT1264901B1 (it) * 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
US6448253B1 (en) 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
CN100384847C (zh) 2000-05-26 2008-04-30 先灵公司 腺苷A2a受体拮抗剂
KR20030076633A (ko) * 2001-02-05 2003-09-26 가부시키 가이샤 오오쯔카 세이야쿠 고우죠우 트리아조로퀴나졸린 및 피라졸로 트리아조로피리미딘유도체, 의약조성물,아데노신 에이3 수용체 친화제,안압저하제, 녹내장의 예방 및 치료를 위한 제제 및안압저하 방법
CA2446099A1 (en) * 2001-05-01 2002-11-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
KR20050044593A (ko) * 2001-11-30 2005-05-12 쉐링 코포레이션 아데노신 Ａ2ａ 수용체 길항제
ES2278353T3 (es) * 2003-10-28 2007-08-01 Schering Corporation Procedimiento para preparar 5-amino-pirazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pirimidinas sustituidas.
ATE377599T1 (de) * 2003-12-01 2007-11-15 Schering Corp Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen

Also Published As

Publication number Publication date
JP2011116795A (ja) 2011-06-16
MXPA06004722A (es) 2006-07-05
EP1678182A1 (en) 2006-07-12
ZA200603307B (en) 2008-07-30
ES2278353T3 (es) 2007-08-01
CA2543431A1 (en) 2005-05-19
DE602004004677T2 (de) 2007-11-15
US7223861B2 (en) 2007-05-29
CY1106393T1 (el) 2011-10-12
CN1898246B (zh) 2010-10-27
US20090005559A1 (en) 2009-01-01
CN101899050A (zh) 2010-12-01
US7601833B2 (en) 2009-10-13
SI1678182T1 (sl) 2007-06-30
PT1678182E (pt) 2007-04-30
US20070203340A1 (en) 2007-08-30
CN1898246A (zh) 2007-01-17
DE602004004677D1 (de) 2007-03-22
EP1678182B1 (en) 2007-02-07
DK1678182T3 (da) 2007-06-04
ATE353331T1 (de) 2007-02-15
JP4782693B2 (ja) 2011-09-28
WO2005044819A1 (en) 2005-05-19
JP2007509948A (ja) 2007-04-19
HRP20070063T3 (en) 2007-04-30
HK1086008A1 (en) 2006-09-08
US20050090492A1 (en) 2005-04-28
US20090326241A1 (en) 2009-12-31
US7439361B2 (en) 2008-10-21
AR046560A1 (es) 2005-12-14

Similar Documents

Publication Publication Date Title
IL182177A0 (en) Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
HK1085466A1 (en) 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c] - pyrimidine adenosine a2a receptor antagonists
IL170680A0 (en) 8 - SUBSTITUTED - 6,7,8,9 -TETRAHYDROPYRIMIDO [1,2-a] PYRIMIDIN - 4 - ONE DERIVATIVES
TWI365189B (en) Novel pyrrolo[3,2-d]pyrimidin-4-one derivatives
HK1095818A1 (en) Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine-a2a-receptor antagonists
ZA200702541B (en) Process for preparing 4,5-dihydro-pyrazolo [3,4-c]pyrid-2-ones
IL175812A0 (en) Pyrrolo [2,3-d] pyrimidine compounds for treating transplant rejection
IL160878A0 (en) Imidazo (4,3-e)-1,2,4-triazolo (1,5-c) pyrimidines as adenosine a2a receptor antagonists
PL379009A1 (pl) Pochodne pirazolo [1,5-a] [1,3,5] triazyny jako ligandy receptora kanabinoidowego
IL220174A0 (en) 5-AMINO - {PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE}-2-AND 7-SUBSTITUTED DERIVATIVES AS ADENOSINE A2A RECEPTOR INHIBITORS
EP1831226A4 (en) CHIRAL COMPOUNDS WITH CYCLE 1,2 IMIDAZO 4,5-c FUSIONNE
EP1831221A4 (en) CHIRAL COMPOUNDS 1,2 IMIDAZO 4,5-C SUBSTITUTED FUSED CORE
ZA200604960B (en) Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-A]pyrimidin-6-onederivatives
IL186422A0 (en) Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives
ZA200507192B (en) Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido [1,2-A] pyrimidin-4-one derivatives
IL175753A0 (en) PROCESSES FOR THE PREPARATION OF PYRAZOLO [1,5-a]-1,3,5-TRIAZINES AND INTERMEDIATES THEREOF
PL1678182T3 (pl) Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn
PL370565A1 (pl) Pochodne 5-metoksy-8-arylo[1,2,4]triazolo[1,5-a]pirydyny
HUP0301399A3 (en) Process for the preparation of 2-amino-5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidine
WO2005054245A3 (en) Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
GB2424883B (en) Process for preparing pyrrolo[2, 1-c] [1,4] benzodiazepine hybrids
IL176471A0 (en) Process for the preparation of triazolopyrimidines
GB2425309B (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers
HUP0401991A3 (en) Method for producing of substituted imidazo[1,2-a]-5,6,7,8-tetrahydropyridine-8-on derivatives
IL173347A0 (en) 7-SUBSTITUTED 3-NITRO-PYRAZOLO[1,5-a] PYRIMIDINES